Quantitative Proteomics to Unravel Signalling in Rare Cells

Wednesday, January 27, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Multi-Omics Stage
Day 1 - Wednesday 27th January
Proteomics

Information

  • Signalling analysis in rare cell populations requires ultrasensitive methodologies capable of capturing global proteomic changes and post-translational modifications. 
  • SPARCE (Streamlined Phosphoproteomic Analysis of Rare Cells) enables nanogram-scale phosphoproteomic profiling from as few as hundreds to thousands of cells. 
  • Using SPARCE, we characterised treatment-resistant quiescent states in glioblastoma and identified signalling signatures associated with measurable residual disease in acute myeloid leukaemia patients.